| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT
|
Krawitz, Peter M.
|
|
|
122 |
7 |
p. 1312-1315
|
artikel
|
| 2 |
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia
|
Yang, Guang
|
|
|
122 |
7 |
p. 1222-1232
|
artikel
|
| 3 |
Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109(6):2293-2302.
|
|
|
|
122 |
7 |
p. 1325-1326
|
artikel
|
| 4 |
Cancer makes new friends with old tricks
|
Dazzi, Francesco
|
|
|
122 |
7 |
p. 1093-1094
|
artikel
|
| 5 |
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
|
Bhatt, Shruti
|
|
|
122 |
7 |
p. 1233-1242
|
artikel
|
| 6 |
CMV: a warrior against leukemia?
|
Ljungman, Per
|
|
|
122 |
7 |
p. 1101-1102
|
artikel
|
| 7 |
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
|
Green, Margaret L.
|
|
|
122 |
7 |
p. 1316-1324
|
artikel
|
| 8 |
Cold agglutinin disease
|
Swiecicki, Paul L.
|
|
|
122 |
7 |
p. 1114-1121
|
artikel
|
| 9 |
Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy
|
Ravandi, Farhad
|
|
|
122 |
7 |
p. 1214-1221
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
122 |
7 |
p. i
|
artikel
|
| 11 |
Erythrocytosis: the HIF pathway in control
|
Franke, Kristin
|
|
|
122 |
7 |
p. 1122-1128
|
artikel
|
| 12 |
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
|
Zhang, Hua
|
|
|
122 |
7 |
p. 1105-1113
|
artikel
|
| 13 |
Genetic interaction between Kit and Scl
|
Lacombe, Julie
|
|
|
122 |
7 |
p. 1150-1161
|
artikel
|
| 14 |
Hepatosplenic T-cell lymphoma appearing in the peripheral blood
|
Kojima, Minoru
|
|
|
122 |
7 |
p. 1103
|
artikel
|
| 15 |
Importance of subsegmental pulmonary embolism
|
Raskob, Gary E.
|
|
|
122 |
7 |
p. 1094-1095
|
artikel
|
| 16 |
Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
|
Fischer, Kathelijn
|
|
|
122 |
7 |
p. 1129-1136
|
artikel
|
| 17 |
Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity
|
Cagnetta, Antonia
|
|
|
122 |
7 |
p. 1243-1255
|
artikel
|
| 18 |
Kunnumakkara AB, Nair AS, Ahn KS, et al. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-κB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood. 2007;109(12):5112-5121.
|
|
|
|
122 |
7 |
p. 1327-1328
|
artikel
|
| 19 |
Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions
|
Mathiesen, Line
|
|
|
122 |
7 |
p. 1174-1181
|
artikel
|
| 20 |
Morak M, Attarbaschi A, Fischer S, et al. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Blood. 2012;120(26):5134-5142.
|
|
|
|
122 |
7 |
p. 1328
|
artikel
|
| 21 |
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
|
Morin, Ryan D.
|
|
|
122 |
7 |
p. 1256-1265
|
artikel
|
| 22 |
Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells
|
Lee, Jung Bok
|
|
|
122 |
7 |
p. 1162-1173
|
artikel
|
| 23 |
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
|
Schnaiter, Andrea
|
|
|
122 |
7 |
p. 1266-1270
|
artikel
|
| 24 |
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)
|
Radford, John
|
|
|
122 |
7 |
p. 1137-1143
|
artikel
|
| 25 |
Outcome of SSPE
|
|
|
|
122 |
7 |
p. 1329
|
artikel
|
| 26 |
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
|
Cramer-Morales, Kimberly
|
|
|
122 |
7 |
p. 1293-1304
|
artikel
|
| 27 |
Philadelphia chromosome positive acute B-lymphoblastic leukemia with extreme leukocytosis
|
Bhatnagar, Vishal
|
|
|
122 |
7 |
p. 1104
|
artikel
|
| 28 |
Plzf drives MLL-fusion–mediated leukemogenesis specifically in long-term hematopoietic stem cells
|
Ono, Ryoichi
|
|
|
122 |
7 |
p. 1271-1283
|
artikel
|
| 29 |
PNH from mutations of another PIG gene
|
Luzzatto, Lucio
|
|
|
122 |
7 |
p. 1099-1100
|
artikel
|
| 30 |
Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition
|
Gobbi, Giuliana
|
|
|
122 |
7 |
p. 1305-1311
|
artikel
|
| 31 |
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism
|
den Exter, Paul L.
|
|
|
122 |
7 |
p. 1144-1149
|
artikel
|
| 32 |
Ruxolitinib targets DCs: for better or worse?
|
Tefferi, Ayalew
|
|
|
122 |
7 |
p. 1096-1097
|
artikel
|
| 33 |
Sethi G, Ahn KS, Pandey MK, Aggarwal BB. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB-regulated gene products and TAK1-mediated NF-κB activation. Blood. 2007;109(7):2727-2735.
|
|
|
|
122 |
7 |
p. 1327
|
artikel
|
| 34 |
Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4+ T cells
|
Hahn, Susanne A.
|
|
|
122 |
7 |
p. 1182-1191
|
artikel
|
| 35 |
Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor–induced interleukin 12 synthesis
|
Wölfl, Matthias
|
|
|
122 |
7 |
p. 1203-1213
|
artikel
|
| 36 |
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
|
Heine, Annkristin
|
|
|
122 |
7 |
p. 1192-1202
|
artikel
|
| 37 |
The sequence of events in diffuse large B-cell lymphoma
|
Gribben, John G.
|
|
|
122 |
7 |
p. 1097-1098
|
artikel
|
| 38 |
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
|
Höglund, Martin
|
|
|
122 |
7 |
p. 1284-1292
|
artikel
|
Tijdschrift beschrijving